Comparison of ASDAS and BASDAI as a measure of disease activity in axial psoriatic arthritis

dc.contributor.authorKilic, Gamze
dc.contributor.authorKilic, Erkan
dc.contributor.authorNas, Kemal
dc.contributor.authorKarkucak, Murat
dc.contributor.authorCapkin, Erhan
dc.contributor.authorDagli, Abdullah Zubeyir
dc.contributor.authorCevik, Remzi
dc.date.accessioned2024-04-24T16:02:00Z
dc.date.available2024-04-24T16:02:00Z
dc.date.issued2015
dc.departmentDicle Üniversitesien_US
dc.description.abstractThe aim of this study was to compare the discriminative ability of Ankylosing Spondylitis Disease Activity Score (ASDAS) with Bath Ankylosing Spondylitis Activity Disease Activity Index (BASDAI) and other clinical disease activity parameters in patients with axial psoriatic arthritis (axPsA). Patients with axPsA were recruited from Erciyes Spondyloarthritis Cohort (ESPAC) and Anatolian Group for the Assessment in Rheumatic Disease (ANGARD) cohort and were assessed for BASDAI, ASDAS, BASFI (Bath Ankylosing Spondylitis Functional Index), Ankylosing Spondylitis Quality of Life (ASQoL), and visual analog scale (VAS) pain. The discriminant ability of ASDAS-C-reactive protein (-CRP) and ASDAS-erythrocyte sedimentation rate (-ESR) was assessed using standardized mean differences between patients with high and low disease activity. Fifty-four patients with axPsA were included in the study. Both ASDAS scores showed good discriminative ability between high and low disease activity states. Both ASDAS versions and BASDAI had relatively high area under the curve (AUC) according to ASAS partial remission, patient and physician global assessments in receiver operating characteristic (ROC) curve analysis. There was no significant difference between AUC scores for the models that compared ASDAS-CRP and ASDAS-ESR with BASDAI for each individual definition of disease activity states. ASDAS versions and BASDAI showed good similar discriminative ability between high and low disease activity as reflected by the AUC analysis in axPsA. The cutoff values for inactive disease and high disease activity were relatively similar to predefined cutoff values for AS. Further, prospective validation is now required to identify the appropriate assessment tools and cutoff values in axPsA.en_US
dc.identifier.doi10.1007/s10067-014-2734-8
dc.identifier.endpage521en_US
dc.identifier.issn0770-3198
dc.identifier.issn1434-9949
dc.identifier.issue3en_US
dc.identifier.pmid24985042
dc.identifier.scopus2-s2.0-84939879138
dc.identifier.scopusqualityQ1
dc.identifier.startpage515en_US
dc.identifier.urihttps://doi.org/10.1007/s10067-014-2734-8
dc.identifier.urihttps://hdl.handle.net/11468/14563
dc.identifier.volume34en_US
dc.identifier.wosWOS:000350677600015
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherSpringer London Ltden_US
dc.relation.ispartofClinical Rheumatology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAsdasen_US
dc.subjectAxial Psoriatic Arthritisen_US
dc.subjectBasdaien_US
dc.subjectDisease Activityen_US
dc.titleComparison of ASDAS and BASDAI as a measure of disease activity in axial psoriatic arthritisen_US
dc.titleComparison of ASDAS and BASDAI as a measure of disease activity in axial psoriatic arthritis
dc.typeArticleen_US

Dosyalar